SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-289983
Filing Date
2019-11-12
Accepted
2019-11-12 16:28:13
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d819654d10q.htm 10-Q 631121
2 EX-31.1 d819654dex311.htm EX-31.1 6928
3 EX-31.2 d819654dex312.htm EX-31.2 6937
4 EX-32.1 d819654dex321.htm EX-32.1 4928
  Complete submission text file 0001193125-19-289983.txt   5137178

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT orgo-20190930.xml EX-101.INS 1076086
6 XBRL TAXONOMY EXTENSION SCHEMA orgo-20190930.xsd EX-101.SCH 53147
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20190930_cal.xml EX-101.CAL 58111
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20190930_def.xml EX-101.DEF 283545
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20190930_lab.xml EX-101.LAB 419848
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20190930_pre.xml EX-101.PRE 378447
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 191209951
SIC: 2834 Pharmaceutical Preparations